DTC Act of 2025

Hozzl · 2025-07-04T20:14:14Z

Explore the details of House Bill 3789 DTC Act of 2025 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

7/4/2025, 8:14 PM

Summary of Bill HR 3789

The bill "To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information" was introduced in the 119th Congress on June 5, 2025.

Congressional Summary of HR 3789

Drug-price Transparency for Consumers Act of 2025 or the DTC Act of 2025

This bill requires consumer advertisements for prescription drugs and biological products to include certain price information if the drug or biologic is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law.

Specifically, such advertisements must clearly and conspicuously disclose the wholesale price for a 30-day supply of the drug or biologic and may explain that a consumer may pay a different amount for the drug or biologic depending on the consumer's health insurance coverage.

The requirement does not apply to advertisements for drugs or biologics with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 3789

Bill HR 3789 is currently in the status of Bill Introduced since June 5, 2025. Bill HR 3789 was introduced during Congress 119 and was introduced to the House on June 5, 2025. Bill HR 3789's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of June 5, 2025

Bipartisan Support of Bill HR 3789

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 3789

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 3789

To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for prescription drugs and biological products include an appropriate disclosure of pricing information.

Comments

Charlee Howell

1,069

1 year ago

I can't believe this new bill, it's gonna make things so much harder for me and my family. I just don't understand why they would do this to us. It's just not fair. The big picture is just so bleak.